• Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio | Morningstar

    المصدر: Buzz FX / 27 يناير 2025 07:57:30   America/New_York


    Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
    NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.
    Read more...
شارك على،